NICE guidance on cetuximab, bevacizumab, and panitumumab for treatment of metastatic colorectal cancer after first-line chemotherapy

Title
NICE guidance on cetuximab, bevacizumab, and panitumumab for treatment of metastatic colorectal cancer after first-line chemotherapy
Authors
Keywords
-
Journal
LANCET ONCOLOGY
Volume 13, Issue 3, Pages 233-234
Publisher
Elsevier BV
Online
2012-01-25
DOI
10.1016/s1470-2045(12)70044-x

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More